Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology Drugs.

Autor: Balogh EP; Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine, Washington, DC, USA., Bindman AB; University of California, San Francisco, California, USA., Eckhardt SG; University of Texas at Austin's Dell Medical School, Austin, Texas, USA., Halabi S; Duke University, Durham, North Carolina, USA., Harvey RD; Emory University, Atlanta, Georgia, USA., Jaiyesimi I; Beaumont Hospital, Royal Oak, Michigan, USA., Miksad R; Flatiron Health, New York, New York, USA., Moses HL; Vanderbilt University, Nashville, Tennessee, USA., Nass SJ; Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine, Washington, DC, USA., Schilsky RL; American Society of Clinical Oncology, Alexandria, Virginia, USA., Sun S; Janssen Research and Development, Raritan, New Jersey, USA., Torrente JM; Hyman, Phelps & McNamara, P.C., Washington, DC, USA., Warren KE; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.

Publikováno v: The oncologist [Oncologist] 2020 Mar; Vol. 25 (3), pp. e405-e411. Date of Electronic Publication: 2019 Dec 08.